A Single Testing of Serum Amyloid A Levels as a Tool for Diagnosis and Treatment Dilemmas in Familial Mediterranean Fever

Seminars in Arthritis and Rheumatism

Volumn 37, Issue 3, 2007, Pages 182-188

  Berkun, Yackov ^a   Padeh, Shai ^a   Reichman, Brian ^a   Zaks, Nurit ^b   Rabinovich, Einat ^b   Lidar, Merav ^b   Shainberg, Bracha ^c   Livneh, Avi ^b  

^a SHEBA MEDICAL CENTER   (Israel)

^b HELLER INSTITUTE OF MEDICAL RESEARCH   (Israel)

^c MACCABI HEALTHCARE SERVICES   (Israel)

Author keywords

amyloidosis; colchicine; familial Mediterranean fever; inflammation; serum amyloid A

Indexed keywords

AMYLOID A PROTEIN; C REACTIVE PROTEIN; COLCHICINE; SERUM AMYLOID A;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRUG MEGADOSE; FAMILIAL MEDITERRANEAN FEVER; FEMALE; GENETIC ASSOCIATION; GENETIC PARAMETERS; HOMOZYGOSITY; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEINURIA; RISK ASSESSMENT;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; COLCHICINE; DRUG MONITORING; FAMILIAL MEDITERRANEAN FEVER; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; MALE; PATIENT COMPLIANCE; POINT MUTATION; SERUM AMYLOID A PROTEIN; TUBULIN MODULATORS;

EID: 34948870193     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2007.03.005     Document Type: Article

References (21)

1. Sohar E., Gafni J., Pras M., and Heller H. Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med 43 (1967) 227-253
2. Livneh A., Langevitz P., Zemer D., Padeh S., Migdal A., Sohar E., et al. The changing face of familial Mediterranean fever. Semin Arthritis Rheum 26 (1996) 612-627
3. Liepnieks J.J., Kluve-Beckerman B., and Benson M.D. Characterization of amyloid A protein in human secondary amyloidosis: the predominant deposition of serum amyloid A1. Biochim Biophys Acta 1270 (1995) 81-86
4. Merlini G., and Bellotti V. Molecular mechanisms of amyloidosis. N Engl J Med 349 (2003) 583-596
5. Cunnane G. Amyloid precursors and amyloidosis in inflammatory arthritis. Curr Opin Rheumatol 13 (2001) 67-73
6. Tunca M., Kirkali G., Soyturk M., Akar S., Pepys M.B., and Hawkins P.N. Acute phase response and evolution of familial Mediterranean fever. Lancet 353 (1999) 1415
7. Duzova A., Bakkaloglu A., Besbas N., Topaloglu R., Ozen S., Ozaltin F., et al. Role of A-SAA in monitoring subclinical inflammation and in colchicine dosage in familial Mediterranean fever. Clin Exp Rheumatol 21 (2003) 509-514
8. Korkmaz C., Ozdogan H., Kasapcopur O., and Yazici H. Acute phase response in familial Mediterranean fever. Ann Rheum Dis 61 (2002) 79-81
9. Gillmore J.D., Lovat L.B., Persey M.R., Pepys M.B., and Hawkins P.N. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet 358 (2001) 24-29
10. Lachmann H.J., Sengul B., Yavuzsen T.U., Booth D.R., Booth S.E., Bybee A., et al. Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology (Oxford) 45 (2006) 746-750
11. Zemer D., Pras M., Sohar E., Modan M., Cabili S., and Gafni J. Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Engl J Med 314 (1986) 1001-1005
12. Livneh A., Langevitz P., Zemer D., Zaks N., Kees S., Lidar T., et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40 (1997) 1879-1885
13. Zaks N., Shinar Y., Padeh S., Lidar M., Mor A., Tokov I., et al. Analysis of the three most common MEFV mutations in 412 patients with familial Mediterranean fever. Isr Med Assoc J 5 (2003) 585-588
14. Padeh S., Shinar Y., Pras E., Zemer D., Langevitz P., Pras M., et al. Clinical and diagnostic value of genetic testing in 216 Israeli children with familial Mediterranean fever. J Rheumatol 30 (2003) 185-190
15. Livneh A., Langevitz P., Shinar Y., Zaks N., Kastner D.L., Pras M., et al. MEFV mutation analysis in patients suffering from amyloidosis of familial Mediterranean fever. Amyloid 6 (1999) 1-6
16. Cazeneuve C., Sarkisian T., Pecheux C., Dervichian M., Nedelec B., Reinert P., et al. MEFV-Gene analysis in armenian patients with Familial Mediterranean fever: diagnostic value and unfavorable renal prognosis of the M694V homozygous genotype-genetic and therapeutic implications. Am J Hum Genet 65 (1999) 88-97
17. Tunca M., Akar S., Onen F., Ozdogan H., Kasapcopur O., Yalcinkaya F., et al. Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore) 84 (2005) 1-11
18. Livneh A., and Langevitz P. Diagnostic and treatment concerns in familial Mediterranean fever. Baillieres Best Pract Res Clin Rheumatol 14 (2000) 477-498
19. Kogan A., Shinar Y., Lidar M., Revivo A., Langevitz P., Padeh S., et al. Common MEFV mutations among Jewish ethnic groups in Israel: high frequency of carrier and phenotype III states and absence of a perceptible biological advantage for the carrier state. Am J Med Genet 102 (2001) 272-276
20. Gershoni-Baruch R., Brik R., Zacks N., Shinawi M., Lidar M., and Livneh A. The contribution of genotypes at the MEFV and SAA1 loci to amyloidosis and disease severity in patients with familial Mediterranean fever. Arthritis Rheum 48 (2003) 1149-1155
21. Gershoni-Baruch R., Brik R., Lidar M., Shinawi M., and Livneh A. Male sex coupled with articular manifestations cause a 4-fold increase in susceptibility to amyloidosis in patients with familial Mediterranean fever homozygous for the M694V-MEFV mutation. J Rheumatol 30 (2003) 308-312